Salud y calidad de vida

NEW PSILOCIN DERIVATIVE PRODRUGS
18/11/2026 - [0001] The present invention relates to new prodrugs of tryptamine represented by Formula (I), and a method of preparation thereof. In addition, the invention pertains to their use as a...
COMPOSITIONS CONTAINING ISOLATED PLANT-DERIVED AND ADIPOSE STEM CELL-DERIVED EXOSOMES
29/10/2026 - [0000] The present disclosure provides a composition containing a purified population of extracellular vesicles (EVs) isolated from one or more biological samples, wherein the purified...
CULTURE MEDIUM FOR CULTURING MESENCHYMAL STEM CELLS, CULTURE MEDIUM KIT FOR CULTURING MESENCHYMAL STEM CELLS, CULTURE MEDIUM ADDITIVE, AND METHOD FOR PRODUCING CELL THERAPEUTIC AGENT
29/10/2026 - The present invention addresses the problem of providing: a culture medium for culturing mesenchymal stem cells and a culture medium kit for culturing mesenchymal stem cells, which are capable of...
ANTI-ΑVΒ6 ANTIBODY CONJUGATES, COMPOSITIONS COMPRISING ANTI- ΑVΒ6 ANTIBODY CONJUGATES AND METHODS OF MAKING AND USING ANTI-ΑVΒ6 ANTIBODY CONJUGATES
12/11/2026 - The present disclosure relates to antibodies and antibody conjugates that selectively bind to αvβ6 and its isoforms and homologs, and compositions comprising the antibodies. Also provided are...
BRM AND BRG1 TARGETING COMPOUNDS AND ASSOCIATED METHODS OF USE
12/11/2026 - The disclosure is directed to compounds of Formula (IA) Pharmaceutical compositions comprising compounds of Formula (IA), as well as methods of their use and preparation, are also described.
DEXTRAN-BASED PLATFORM FOR TARGETED DELIVERY OF A PAYLOAD
12/11/2026 - The invention relates to a nanoparticle carrier for cell-targeted delivery of one or more therapeutic agent(s) to a mammalian cell, wherein the agent is capable of modulating the properties of a...
FBXO31 LIGANDS
12/11/2026 - This disclosure features chemical entities (e.g., a compound or a pharmaceutically acceptable salt thereof) that bind to F-box protein 31 (FBXO31). The FBXO31-binding chemical entities are useful,...
COMPOSITIONS AND METHODS FOR INDUCING AND ENHANCING ANTI-CANCER IMMUNE RESPONSES
12/11/2026 - The present disclosure provides multi-specific binding proteins and uses thereof for inducing and enhancing anti-cancer immune responses in a subject.
ANTI-AVB6 ANTIBODIES, COMPOSITIONS COMPRISING ANTI-AVB6 ANTIBODIES AND METHODS OF MAKING AND USING ANTI-AVB6 ANTIBODIES
12/11/2026 - The present disclosure relates to antibodies and antibody conjugates that selectively bind to αvβ6 and its isoforms and homologs, and compositions comprising the antibodies and antibody...
MODULATION OF TRANSCRIPTION FACTOR EB ACTIVITY BY N-ACETYL LEUCINE TO TREAT DISORDERS
12/11/2026 - The present disclosure provides methods of activating transcription factor EB (TFEB) activity, modulating lysosomal calcium levels, and/or normalizing calcium signaling in a cell of a subject,...
ANTIBODY MOLECULE TARGETING SYNDECAN-1 FOR USE IN THE TREATMENT OF MULTIPLE MYELOMA AND PLASMACYTOMA
12/11/2026 - Antibody molecule targeting Syndecan-1 for use in the treatment of multiple myeloma and plasmacytoma The invention pertains to an anti-CD138 antibody molecule capable of binding CD138. The...
MODULATION OF TRANSCRIPTION FACTOR EB ACTIVITY BY N-ACETYL LEUCINE TO TREAT DISORDERS
12/11/2026 - The present disclosure provides methods of activating transcription factor EB (TFEB) activity, modulating lysosomal calcium levels, and/or normalizing calcium signaling in a cell of a subject,...
USES OF AND COMPOSITIONS INCORPORATING CLOSTRIDIAL TOXINS
29/10/2026 - A composition and method are disclosed for treating autonomic nervous system disorders and related conditions, including pelvic floor dysfunctions. A Clostridial neurotoxin such as a botulinum...
THERAPEUTIC ENGINEERED NUCLEIC ACIDS AND METHODS OF USE THEREOF
12/11/2026 - Several embodiments disclosed herein relate to engineered therapeutic nucleic acids and methods and compositions for treatment of a heart condition or an inflammatory condition using the same.
NOVEL SCN10A RNAi AGENTS AND USES THEREOF
29/10/2026 - The present invention relates to therapeutic compounds, novel RNA interference (RNAi) agents, that decrease expression of the Voltage-Gated Sodium Channel Alpha Subunit 10 (SCN10A) gene, which...
METHODS AND COMPOSITIONS
12/11/2026 - The invention relates to protein-based materials such as fibres, films and hydrogels. The proteins comprise a concatemer of at least two beta solenoids. The fibres, films and hydrogels have a...
Compositions, Systems and Methods for Radiotherapy
12/11/2026 - Systems and methods for image-guided radiotherapy drug-delivery that include use of polydopamine materials. In preferred aspects, the present systems and methods include a therapeutic composition...
Energy Dissipation and Scour Prevention Safety Device for Overflow Port of Barrier Dam
19/10/2026 - The invention discloses an energy dissipation and scour prevention safety device for overflow port of barrier dam, which includes several first deep-buried rods. The several first deep-buried rods...
BOILER FURNACE DEAD-ZONE-FREE IMPACT DESLAGGING DEVICE
22/10/2026 - The invention is applicable to the technical field of coal-fired boiler furnace coking treatment, providing a dead-zone-free impact deslagging device for a boiler furnace, comprising a...
ARCHITECTURAL ROOM CONVERSION STRUCTURE FOR MEDICAL FACILITIES
21/10/2026 - The invention discloses a medical architectural room conversion structure in the field of architectural technology, addressing operating theatre shortages in emergencies. It comprises a ward body,...
ANTIBODIES AND RADIOPHARMACEUTICAL COMPLEXES TARGETING CEACAM5
11/11/2026 - [0001] The present invention relates to antigen binding proteins that specifically bind to a MAGE-A3 antigenic peptide wherein said antigenic peptide is in a complex with a major...